跳至主要内容
临床试验/EUCTR2017-003489-28-AT
EUCTR2017-003489-28-AT进行中(未招募)1 期

Influence of high dose vitamin D3 intake on outcome in pancreatic cancer surgery: prospective, randomized, open, controlled study - The VITDCUT Study

Medizinische Universität Graz0 个研究点目标入组 60 人开始时间: 2018年2月13日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • both sexes
  • vitamin D deficiency (< 20ng/ml)
  • patients > 18 years of age
  • pancreatic Cancer
  • surgical intervention/non-surgical Intervention
  • signed written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 18
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 42

排除标准

  • patients < 18 years of age
  • contraindication for oral vitamin D intake
  • hypercalcemia (> 2.65 mmol/l total calcium and/or > 1.35 mmol/l ionized calcium at screening)
  • other ongoing vitamin D conducted trial
  • known kidney stones, active tuberculosis or sarcoidosis (in the last 12 months)
  • normal vitamin D serum levels
  • metastasized pancreatic Cancer
  • missing written informed consent

研究者

相似试验